Table 1.
Demographic, clinical, and polysomnographic data.
| MPA | CON | p* | |
|---|---|---|---|
| (N=21) | (N=21) | ||
| Age (years) | 34.1 (11.5) | 34.0 (11.8) | 0.98 |
| BMI (kg/m2) | 39.0 (9.5) | 37.0 (9.6) | 0.50 |
| TST (min) | 382.4 (99.8) | 415.6 (109.1) | 0.31 |
| WASO (min) | 73.8 (65.0) | 58.6 (39.6) | 0.36 |
| SE (%) | 79.2 (16.6) | 83.7 (9.0) | 0.28 |
| SOL (min) | 22.7 (29.6) | 19.6 (15.5) | 0.67 |
| N1 (%) | 11.8 (8.3) | 9.9 (8.4) | 0.48 |
| N2 (%) | 61.4 (10.8) | 62.2 (10.3) | 0.80 |
| N3 (%) | 12.1 (9.4) | 9.7 (7.3) | 0.36 |
| REM (%) | 14.7 (8.6) | 18.2 (7.8) | 0.18 |
| REML (min) | 137.9 (102.7) | 148.9 (85.9) | 0.71 |
| AHI (#/hr) | 3.3 (4.2) | 1.8 (3.0) | 0.19 |
| PLMAI (#/hr) | 3.3 (2.9) | 2.0 (1.6) | 0.09 |
MPA, (depot) medroxyprogesterone acetate; CON, control; BMI, body mass index (kg/m2), TST, total sleep time; WASO, wake after sleep onset; AI, arousal index; SE, sleep efficiency (TST/time in bed); SOL, sleep onset latency; N1/2/3, NREM stage 1/2/3 (% of TST); REM, stage REM (% of TST); REML, REM latency (time from sleep onset to first REM sleep epoch); AHI, apnea-hypopnea index; PLMAI, periodic limb movement arousal index.
Values are displayed as mean (standard deviation).
*
p-value derived using 2-tailed, independent samples t-tests.